股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 天安卓健有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | 本月底法定/註冊股本總額： HKD 300,000,000 FF301 第 1 頁 共 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年8月31日 | 狀態: | 新提交 | | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | 公司名稱: | 天安卓健有限公司 | | | | 呈交日期: | 2025年9月1日 | | | | I. 法定/註冊股本變動 | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000,000 | HKD | | 0.01 HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 30 ...

天安卓健(00383)发布公告，于2025年8月28日斥资8500港元回购股份1万股。 ...

Group 1 - The company Tianan Health (00383) announced a share buyback plan, intending to repurchase 10,000 shares at a cost of HKD 8,500 [1]

Group 1 - The company Tianan Health (00383.HK) announced a share buyback plan [1] - The buyback will occur on August 28, 2025, for a total of 10,000 shares [1] - The repurchase price is set at HKD 0.85 per share, totaling HKD 8,500 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) | | | FF305 第 2 頁 共 7 頁 v 1.3.0 FF305 表格類別： 股票 狀態： 新提交 公司名稱： 天安卓健有限公司 呈交日期： 2025年8月28日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00383 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股 ...

Core Insights - Yunnan Province is advancing the integration of green electricity and advanced manufacturing, with a focus on building zero-carbon parks and promoting high-quality regional economic development through clean energy transmission [1][2] Group 1: Green Energy Development - Yunnan's total power generation capacity exceeds 160 million kilowatts, with over 90% from clean energy and nearly 40% from renewable sources [1] - The province has a new energy storage capacity exceeding 5 million kilowatts, and industries such as green aluminum, silicon photovoltaic, and new energy batteries are expanding [1] Group 2: Green Certificate System - Yunnan is enhancing its green energy development efforts, with green electricity trading volume reaching 1.6 billion kilowatt-hours last year [1] - The province aims for full coverage of green certificate issuance, with 240 million green certificates issued by the end of July this year [1][2] - The efficiency of data collection for green certificate issuance has improved by 60% due to government-enterprise collaboration [2] Group 3: Policy and Implementation - A joint implementation plan has been released by Yunnan's Development and Reform Commission, Industrial and Information Technology Department, and Energy Bureau to promote local conversion of green electricity resources [2] - The plan outlines six pathways to deepen the integration of green electricity with advanced manufacturing, facilitating the green and low-carbon transformation of industries [2]

Group 1 - The article provides an overview of the investment activities of Hong Kong-listed companies on August 11, 2025, including new stock activities, earnings announcements, shareholder meetings, and dividend distributions [1] Group 2 - New stock activities include companies such as ZhiNuo Pharmaceutical-B (currently in the IPO process) and Zhonghui Biotechnology-B (listing date) [1] - Earnings announcements are scheduled for companies like Baosheng International, Yuanyuan Group, and Kang Shifu Holdings among others [1] - Shareholder meetings will be held for companies including Huatai Textile, Shandong Gold, and Sichuan Chengyu Expressway [1] - Dividend distributions are noted for companies like Jianbei Miao Miao and Kangnait Optical, with specific ex-dividend and payment dates mentioned [1]

Core Viewpoint - Tianan Health (00383) reported a decline in revenue and profit for the six months ending June 30, 2025, primarily due to decreased operational income in the medical segment and increased non-cash fair value losses on investment properties [1] Financial Performance - The company achieved revenue of HKD 783 million, a year-on-year decrease of 4.67% [1] - Profit attributable to shareholders was HKD 11.979 million, down 44.69% year-on-year [1] - Basic earnings per share were HKD 0.0111 [1] Contributing Factors - The decline in revenue and profit was mainly attributed to reduced operational income in the medical segment [1] - There was an increase in non-cash fair value losses on investment properties [1] - However, this decline was partially offset by a reduction in employee benefit expenses, net unrealized exchange gains, and decreased income tax expenses [1]

Core Viewpoint - Tianan Health (00383) announced that Dr. Wang Yongquan will succeed Mr. Jiang Muxian as the chairman of the nomination committee starting from August 1, 2025, while Mr. Jiang will remain a member of the nomination committee [1] Group 1 - Dr. Wang Yongquan is currently a member of the company's nomination committee [1] - Mr. Jiang Muxian will continue to serve as a member of the nomination committee after his transition [1]